Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €79.24 EUR
Change Today +0.32 / 0.41%
Volume 0.0
As of 6:07 AM 08/5/15 All times are local (Market data is delayed by at least 15 minutes).

cardinal health inc (CLH) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/13/15 - €86.14
52 Week Low
08/8/14 - €51.37
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARDINAL HEALTH INC (CLH)

cardinal health inc (CLH) Related Businessweek News

View More BusinessWeek News

cardinal health inc (CLH) Details

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, specialty pharmaceutical, and consumer products to retailers, including chain and independent drug stores and pharmacy departments of supermarkets and mass merchandisers; hospitals; and other healthcare providers. This segment offers distribution, inventory management, data reporting, new product launch support, and contract pricing and chargeback administration services to pharmaceutical manufacturers; operates nuclear pharmacies and cyclotron facilities that manufacture, prepare, and deliver radiopharmaceuticals for use in nuclear imaging and other procedures in hospitals and physician offices; franchises retail pharmacies under the Medicine Shoppe and Medicap brands; provides pharmacy services to hospitals and other healthcare facilities; and offers logistics, marketing, and other services. This segment also provides various consulting and other services to pharmaceutical manufacturers, third-party payors, and healthcare providers. The Medical segment distributes a range of medical, surgical, and laboratory products to hospitals, ambulatory surgery centers, clinical laboratories, physician offices, and other healthcare providers; and offers supply chain services, including spend, distribution, and inventory management services to healthcare providers. This segment also develops, manufactures, and sources a line of private brand medical and surgical products comprising surgical drapes, gowns, and apparel; exam and surgical gloves; and fluid suction and collection systems, as well as sterile and non-sterile procedure kits directly or through third-party distributors. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.

35,000 Employees
Last Reported Date: 07/30/15
Founded in 1979

cardinal health inc (CLH) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.3M
Chief Financial Officer
Total Annual Compensation: $647.7K
Chief Executive Officer of Medical Segment
Total Annual Compensation: $647.7K
Chief Legal and Compliance Officer
Total Annual Compensation: $508.5K
Executive Officer
Total Annual Compensation: $756.9K
Compensation as of Fiscal Year 2014.

cardinal health inc (CLH) Key Developments

Cardinal Health, Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015

Cardinal Health, Inc. Presents at Piper Jaffray Heartland Summit, Jun-23-2015 . Venue: Minneapolis, Minnesota, United States. Speakers: George S. Barrett, Chairman, Chief Executive Officer and Chairman of Executive Committee.

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal 2016 and 2017

Cardinal Health, Inc. announced that as a result of planned acquisition and the pending acquisition of Cordis, the company is providing its preliminary expectations for fiscal 2016. For the period, the company expects non-GAAP diluted EPS from continuing operations of $4.75 to $5.05. This range is based on the assumptions that the THDG transaction closes in the first quarter of fiscal 2016. The accretion in non-GAAP diluted earnings per share (EPS) from continuing operations is greater than $0.15 per share in fiscal 2016, net of the $0.03 to $0.04 per share of interest expense for the related debt financing. For the fiscal 2017, Cardinal Health expects accretion in non-GAAP diluted EPS of more than $0.20 and for accretion to be increasingly greater thereafter.

Cardinal Health, Inc. Approves Increase Quarterly Dividend, Payable on July 15, 2015

Cardinal Health announced that its board of directors approved a 13% increase in the company's quarterly dividend to $0.3870 per share, or $1.55 per share on an annualized basis. The quarterly dividend is payable on July 15, 2015 to shareholders of record at the close of business on July 1, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLH:GR €79.24 EUR +0.32

CLH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AmerisourceBergen Corp $106.21 USD +0.39
Express Scripts Holding Co $89.31 USD +0.08
Koninklijke Philips NV €25.58 EUR +0.015
Siemens AG €99.51 EUR +0.97
Walgreens Boots Alliance Inc $95.67 USD -0.24
View Industry Companies

Industry Analysis


Industry Average

Valuation CLH Industry Range
Price/Earnings 23.7x
Price/Sales 0.3x
Price/Book 4.5x
Price/Cash Flow 19.0x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDINAL HEALTH INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at